CYTOMEGALOVIRUS (CMV)INFECTION
Clinical trials for CYTOMEGALOVIRUS (CMV)INFECTION explained in plain language.
Never miss a new study
Get alerted when new CYTOMEGALOVIRUS (CMV)INFECTION trials appear
Sign up with your email to follow new studies for CYTOMEGALOVIRUS (CMV)INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common antiviral drug save lives in advanced HIV?
Disease control Not yet recruitingThis study tests whether valganciclovir, a drug that stops CMV from multiplying, can safely lower CMV levels in the blood of people with advanced HIV. About 130 adults and adolescents with very weak immune systems will receive either the drug or a placebo daily for 4 weeks, while…
Matched conditions: CYTOMEGALOVIRUS (CMV)INFECTION
Phase: PHASE2 • Sponsor: Wits Health Consortium (Pty) Ltd • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
Washing kidneys before transplant may stop hidden virus
Disease control Not yet recruitingThis early-stage trial tests whether treating a donor kidney with a drug called SYN002, while it is kept on a machine outside the body, can safely reduce the risk of passing a common virus (CMV) to the recipient. About 12 adults waiting for a kidney transplant will take part. The…
Matched conditions: CYTOMEGALOVIRUS (CMV)INFECTION
Phase: EARLY_PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Apr 24, 2026 16:05 UTC